SAM
ABBV icon

Strategic Asset Management’s AbbVie ABBV Stock Holding History

Strategic Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$78K Hold
578
– – 0.14% 110
2022
Q2 		$89K Hold
578
– – 0.14% 104
2022
Q1 		$94K Sell
578
-35
-6% -$5.08K 0.13% 109
2021
Q4 		$83K Buy
613
+85
+16% +$10K 0.12% 110
2021
Q3 		$59K Buy
+528
New +$60.3K 0.08% 137

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Strategic Asset Management's ABBV Position: Q3 2022 in Review

Strategic Asset Management held its AbbVie (ABBV) position steady in Q3 2022 at 578 shares worth $78K. The position accounts for 0.14% of the portfolio, ranked #110.

Strategic Asset Management first reported a position in ABBV in Q3 2021 and has held it in 5 quarters since. The position peaked at $94K in Q1 2022. 2,968 funds tracked by Wall St. Rank hold ABBV as of Q3 2022.

  • Strategic Asset Management held 578 shares of AbbVie worth $78K as of Q3 2022.
  • Strategic Asset Management left its AbbVie share count unchanged in Q3 2022.
  • AbbVie made up 0.14% of Strategic Asset Management's portfolio in Q3 2022, its #110 holding.
  • Strategic Asset Management first reported a position in AbbVie in Q3 2021 and has held it in 5 quarters since.
  • Strategic Asset Management's AbbVie position peaked at $94K in Q1 2022.
  • 2,968 funds tracked by Wall St. Rank held AbbVie as of Q3 2022.

Based on Strategic Asset Management's 13F filing for Q3 2022, filed 1 Nov 2022.